Cocaine Didn't Get More Dangerous. Everything Mixed Into It Did.

In 2023, 29,449 people in the United States died with cocaine in their system — up from 15,883 in 2019, an 85% jump in four years, according to CDC’s National Center for Health Statistics data brief on overdose deaths. Almost none of them set out to use an opioid that day.

This is not a cocaine epidemic. It’s a fentanyl epidemic wearing cocaine’s face, killing people who never touched an opioid on purpose.

Cocaine itself hasn’t changed much as a drug. What changed is what’s sitting next to it — on the same table, the same scale, the same distribution chain — as illicitly manufactured fentanyl saturated the entire street drug supply, stimulants included. CDC’s own tracking system found that among the jurisdictions reporting detailed data, nearly 47% of drug overdose deaths in 2023 involved both an opioid and a stimulant together — not because people are increasingly seeking out that combination, but because the stimulant supply is no longer separable from the opioid supply the way it was a decade ago.

If you use cocaine and have never carried naloxone because “that’s for opioid people, not me” — read that number again. You don’t have to use fentanyl on purpose to die from it. You just have to use a cocaine supply that fentanyl has already gotten into, which by 2023 was most of it in much of the country. Naloxone reverses the opioid component of a mixed overdose even when the person had no idea an opioid was involved at all, which is exactly the scenario killing cocaine users who think of themselves as opioid-free.

There’s a real complication in reading this as still getting worse: CDC’s newest data brief shows cocaine-involved deaths actually fell 26.7% between 2023 and 2024, and deaths involving psychostimulants (CDC’s catch-all label, mostly meaning methamphetamine) fell nearly 20% over the same year, tracking a broader national decline in synthetic-opioid-involved deaths that’s driving most overdose categories down together. That’s real and worth naming — but a supply-side dip in a still-record-high number isn’t a return to a cocaine that’s “just cocaine” again. The mechanism that made 2023 the worst year on record for cocaine deaths — fentanyl contamination, not cocaine toxicity — hasn’t gone anywhere, and it doesn’t announce itself before you use.

If you’re a case manager, prescriber, or harm-reduction worker reading this: stop assuming cocaine-only clients are low-risk for an opioid overdose kit. This week, ask every person who reports stimulant-only use whether they’ve ever been offered naloxone — the “that’s not my drug” assumption is precisely the gap these numbers describe, on both sides of the desk.

Naloxone is over-the-counter nationwide now, no prescription, no insurance card required, and it does nothing to you if there turns out to be no opioid in your system — there’s no reason not to have it within reach tonight. This newsroom’s crisis-data coverage has spent this year on opioids and, more recently, methamphetamine; cocaine has gone essentially unmentioned for a month, which is its own kind of dangerous, because the story people aren’t hearing is the one that would change what they carry in their pocket.